Annual report
4887.TEDINET S100ODWA
Period2021-04-01 → 2022-03-31
Filed2022-06-24
StandardIFRS
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 37
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥193.8bn | 2021-04-01 → 2022-03-31 | Cons. | Revenue IFRS |
| Operating income | −¥35.9bn | 2021-04-01 → 2022-03-31 | Cons. | Operating profit loss IFRS |
| Profit before tax | −¥36.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss before tax IFRS |
| Net income (owners) | −¥28.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | −¥41.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss IFRS |
| Total assets | ¥349.5bn | at 2022-03-31 | Cons. | Assets IFRS |
| Total liabilities | ¥149.4bn | at 2022-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥200.1bn | at 2022-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥240.8bn | at 2021-03-31 | Cons. | Equity IFRS |
| Equity (owners) | ¥190.1bn | at 2022-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Cash & equivalents | ¥47.7bn | at 2022-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥54.3bn | at 2021-03-31 | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥34.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥30.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | −¥11.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥-645.53 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥-645.53 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings loss per share IFRS |
| Net assets per share | ¥4,340.32 | at 2022-03-31 | Cons. | Equity to asset ratio IFRS (5-year summary) |
| Equity ratio | 54.4% | at 2022-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| ROE | -13.8% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity IFRS (5-year summary) |
| Employees | 2,968 | at 2022-03-31 | Cons. | Number of employees |
| Revenue | ¥2.2bn | 2021-04-01 → 2022-03-31 | Standalone | Operating revenue1 |
| Operating income | −¥106m | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | −¥230m | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥30.2bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | −¥30.3bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Total assets | ¥192.0bn | at 2022-03-31 | Standalone | Assets |
| Total liabilities | ¥15.5bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥176.6bn | at 2022-03-31 | Standalone | Net assets |
| Cash and deposits | ¥6.8bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-691.14 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥130 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥4,026.47 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 91.8% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -34.3% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 43,791,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Employees | 67 | at 2022-03-31 | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 13
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | ¥0 |
| Japanreportable segment | employees | at 2022-03-31 | 2474 pure |
| Japanreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥163.8bn |
| Japanreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥163.8bn |
| Japanreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥32.4bn |
| USAreportable segment | employees | at 2022-03-31 | 494 pure |
| USAreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥30.0bn |
| USAreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥30.0bn |
| USAreportable segment | segment profit | 2021-04-01 → 2022-03-31 | −¥68.2bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥193.8bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥193.8bn |
| —segment total | segment profit | 2021-04-01 → 2022-03-31 | −¥35.9bn |
| Japanreportable segment | employees | at 2022-03-31 | 67 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 924
| Item | Context | Value | Unit |
|---|---|---|---|
| Name information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E36190-000HiranoJunichiMember | Original text (Japanese)平 野 潤 一 | |
| Date of birth information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E36190-000HiranoJunichiMember | 1955-04-28 | |
| Career summary information about directors and corporate auditors (text) | FilingDateInstant_jpcrp030000-asr_E36190-000HiranoJunichiMember | Text · Plus | |
| Term of office information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E36190-000HiranoJunichiMember | Original text (Japanese)(注)２ | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row5Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row6Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Name of group company holding largest amount of investment shares in group | CurrentYearInstant | Original text (Japanese)沢井製薬株式会社 | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment largest holding company | CurrentYearDuration | Original text (Japanese)取引先との関係強化 | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment largest holding company | CurrentYearDuration | － | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)住友商事株式会社 | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)原薬等の主要窓口商社 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row1Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row2Member | Original text (Japanese)日本化薬株式会社 | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row2Member | Original text (Japanese)医薬品の共同開発先 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row2Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row3Member | Original text (Japanese)株式会社ヤクルト本社 | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row3Member | Original text (Japanese)医薬品の共同開発先 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row3Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row4Member | Original text (Japanese)株式会社メディパルホールディングス | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row4Member | Original text (Japanese)有力医薬品卸 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row4Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row5Member | Original text (Japanese)アルフレッサ ホールディングス株式会社 | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row5Member | Original text (Japanese)有力医薬品卸 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row5Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row6Member | Original text (Japanese)株式会社メディカル一光グループ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row6Member | Original text (Japanese)有力医薬品卸 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row6Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row7Member | Original text (Japanese)ダイト株式会社 | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row7Member | Original text (Japanese)製品製造に関する委受託契約先 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row7Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row8Member | Original text (Japanese)朝日印刷株式会社 | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row8Member | Original text (Japanese)添付資料等の発注先 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row8Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row9Member | Original text (Japanese)株式会社テクノ菱和 | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row9Member | Original text (Japanese)主要設備メンテナンス取引先 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row9Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row10Member | Original text (Japanese)株式会社三菱ＵＦＪフィナンシャル・グループ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row10Member | Original text (Japanese)主要取引金融機関 | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row10Member | Original text (Japanese)有 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment largest holding company | CurrentYearInstant_Row11Member | Original text (Japanese)株式会社三井住友フィナンシャルグループ | |
| Purpose of shareholding quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment largest holding company | CurrentYearInstant_Row11Member | Original text (Japanese)主要取引金融機関 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |